Active ingredients: cytarabine
What it is used for
Cytarabine may be used alone or in combination with other chemotherapeutic agents. It is indicated for induction of remission of leukaemia, particularly for acute myeloid leukaemia, in adults and children. Cytarabine has been used for remission induction in acute lymphocytic leukaemia, chronic myeloid leukaemia and erythroleukaemia; and in the treatment and maintenance therapy of meningeal leukaemia and other meningeal neoplasms.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store between 15-25 degrees Celsius
- Protect from Light
- Lifetime is 18 Months.
Always read the label. If symptoms persist see your healthcare professional.
Clear colourless solution
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. They are Schedule 4: Prescription Only Medicine.
- 1 x 5mL (single onco vial) pack
- 1x500mg/5mL pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. These medicines are Not Scheduled.
- 1x500mg/5mL(E) pack
Is this medicine subsidised?
This medicine may be subsidised which may make it cheaper. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient cytarabine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)